Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,897 | 43,326 | 28,193 | 47,273 | 96,051 |
| Marketable Securities | 73,237 | 82,132 | 118,130 | 113,991 | 72,856 |
| Receivables | 227 | 265 | N/A | 284 | 209 |
| TOTAL | $113,813 | $133,273 | $151,585 | $166,129 | $174,102 |
| Non-Current Assets | |||||
| PPE Net | 1,511 | 1,690 | 1,761 | 1,929 | 2,075 |
| Other Non-Current Assets | 1,717 | 1,719 | 479 | 428 | 420 |
| TOTAL | $3,228 | $3,409 | $2,240 | $2,357 | $2,495 |
| Total Assets | $117,041 | $136,682 | $153,825 | $168,486 | $176,597 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,050 | 1,606 | 231 | 947 | 476 |
| Accrued Expenses | 7,909 | 6,303 | 4,698 | 5,822 | 6,316 |
| TOTAL | $8,959 | $7,909 | $9,857 | $10,462 | $9,478 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 988 | 1,127 | 1,262 | 1,389 | 1,511 |
| TOTAL | $988 | $1,127 | $1,262 | $1,389 | $1,511 |
| Total Liabilities | $9,947 | $9,036 | $11,119 | $11,851 | $10,989 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,998 | 68,996 | 68,946 | 68,887 | 68,887 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -717,631 | -694,409 | -676,858 | -661,107 | -649,686 |
| Other shareholders' equity | 1 | -6 | 8 | 82 | 186 |
| TOTAL | $107,094 | $127,646 | $142,706 | $156,635 | $165,608 |
| Total Liabilities And Equity | $117,041 | $136,682 | $153,825 | $168,486 | $176,597 |